Rapid Micro Biosystems, Inc.
$2.25
▲
5.09%
2026-04-21 09:13:00
www.rapidmicrobio.com
NCM: RPID
Explore Rapid Micro Biosystems, Inc. stock price, valuation, financial statements, dividend history, analyst estimates, and long-term business fundamentals on StockSifting.
Market Cap
$103.66 M
Current Price
$2.25
52W High / Low
$4.94 / $2.01
Stock P/E
—
Book Value
$0.75
Dividend Yield
—
ROCE
-84.08%
ROE
-86.82%
Face Value
—
EPS
$-1
Exp Qtr EPS
—
Sector
Healthcare
Industry
Medical Devices
Employees
171
Beta
1.6
Debt / Equity
71.9
Current Ratio
3.31
Quick Ratio
2.36
Forward P/E
-2.57
Price / Sales
2.89
Enterprise Value
$81.53 M
EV / EBITDA
-1.83
EV / Revenue
2.43
Rating
Strong Buy
Target Price
$8
EPS Forecast (FY)
—
Pros
- Short-term liquidity looks comfortable.
- Valuation is not stretched on P/E basis.
Cons
- Return on equity is on the weaker side.
- Capital efficiency is modest.
- Operating margin is thin.
- Net margin is relatively low.
Sift Stocks
| S.No. | Name | Price | P.E. | Market Cap | Div Yld % | ROCE | ROE | 52Week High/ Low | Book Value |
|---|---|---|---|---|---|---|---|---|---|
| 1. | Pacific Biosciences of California, Inc. | $1.74 | — | $510.38 M | — | -78.39% | -2.13% | $2.73 / $0.85 | $0.02 |
| 2. | TriSalus Life Sciences, Inc. | $4.6 | — | $285.58 M | — | -113.07% | 131.29% | $7.95 / $3.42 | $-0.68 |
| 3. | Neogen Corporation | $9.63 | — | $2.08 B | — | -0.05% | -25.57% | $11.43 / $4.32 | $9.68 |
| 4. | GE HealthCare Technologies Inc. | $71.58 | 15.76 | $32.85 B | 0.19% | 9.93% | 22.38% | $89.77 / $59.95 | $22.77 |
| 5. | Senseonics Holdings, Inc. | $6.87 | — | $287.13 M | — | -67.05% | -1.68% | $15.74 / $5.25 | $1.48 |
| 6. | Beta Bionics, Inc. | $12.91 | — | $576.08 M | — | -24.07% | -40.26% | $32.71 / $8.8 | $6.48 |
| 7. | QuidelOrtho Corporation | $12.89 | — | $877.57 M | — | 1.14% | -46.15% | $38.99 / $11.61 | $28.28 |
Quarterly Results
Figures shown in M / B
| Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|
| Sales | 7.84 M | 7.26 M | 7.21 M | 8.22 M | 7.6 M |
| Operating Profit | -11.37 M | -12.15 M | -11.66 M | -10.23 M | -12.04 M |
| Net Profit | -11.51 M | -11.86 M | -11.26 M | -9.67 M | -11.32 M |
| EPS in Rs | -0.28 | -0.29 | -0.27 | -0.23 | -0.27 |
Profit & Loss
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Sales | 33.59 M | 28.05 M | 22.52 M | 17.13 M |
| Operating Profit | -47.39 M | -49.92 M | -56.56 M | -63.22 M |
| Net Profit | -47.12 M | -46.89 M | -52.47 M | -60.81 M |
| EPS in Rs | -1.14 | -1.14 | -1.27 | -1.47 |
Balance Sheet
Figures shown in M / B
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Total Assets | 74.85 M | 98.17 M | 143.45 M | 190.65 M |
| Total Liabilities | 41.65 M | 22.82 M | 25.46 M | 26.48 M |
| Equity | 33.21 M | 75.35 M | 117.99 M | 164.17 M |
| Current Assets | 61.17 M | 80.92 M | 120.42 M | 138.58 M |
| Current Liabilities | 18.49 M | 17.57 M | 18.99 M | 19.05 M |
Cash Flow
Last available yearly cash flow history
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Operating CF | -44.15 M | -45.08 M | -58.55 M | -54.96 M |
| Investing CF | 36.66 M | 42.15 M | -93.47 M | -13.29 M |
| Financing CF | 0.2 M | 0.15 M | 0.69 M | 216.75 M |
| Free CF | -45.52 M | -46.93 M | -65.29 M | -58.18 M |
| Capex | -1.36 M | -1.84 M | -6.74 M | -3.22 M |
5Y Margin & Growth History
Last 5 year derived history from yfinance annual statements
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Revenue Growth % | 24.57% | 31.44% | — | — |
| Earnings Growth % | 10.63% | 13.71% | — | — |
| Profit Margin % | -167.16% | -232.99% | -354.91% | — |
| Operating Margin % | -177.96% | -251.18% | -368.99% | — |
| Gross Margin % | -0.39% | -24.36% | -49.85% | — |
| EBITDA Margin % | -165.97% | -237.39% | -352.43% | — |
Dividend & Split History
Latest dividend and stock split events stored from yfinance
Dividend History
No dividend history available.
Stock Splits
No stock split history available.